As DNA testing becomes cheaper, it becomes more feasible to screen large numbers of healthy people for their risk of disease.
Pancreatic cancer has historically had among the lowest survival rates of any type of cancer. A recent study that looked at genomic changes reveals some possible clues.
When you share your genetic data – even with the NHS – you don't know where it will end up, or how it will be used.
A freedom of information request reveals that Google wants its AI company DeepMind to get involved in the 100,000 Genomes Project.
A test of all your genes for disease risk is not yet the precision diagnostic and treatment tool we hope it will one day be.
New tools help doctors and breast cancer patients decide whether chemotherapy is needed. A recent study suggested that many can forgo chemo. But the decision is complicated. Here's why.